Fosamax, Actonel & Boniva: Fall 2010 Report Links Drugs To Thigh Bone Injuries

Popular bisphosphonate drugs used to treat osteoporosis – such as Fosamax, Actonel and Boniva – have been linked to increased risks of thigh bone injuries according to a new report published in the Journal of Bone and Mineral Research. In fact, nearly 94% of patients who experienced a thigh bone injury had been taking a bisphosphonate drug at the time.

New Study Shows Increase In Fosamax Injuries / Actonel Injuries / Boniva Injuries

Fosamax, manufactured by Merck & Company, has long been associated with increased risks of osteocronosis of the jaw (ONJ) – also known as jaw death. However, the results of a new study by researchers at the American Society of Bone and Mineral Research (ASBMR) Task Force found that 291 of the 310 patients (94%) in the study who experienced a thigh bone, or femur, injury, had been taking a bisphosphonate drug such as Fosamax, Sanofi Aventis / Warner Chilcott’s Bovina or Roche Holding / GlaxoSmithKline’s Boniva. These drugs are sold generically under the chemical name alendronate.

The task force has urged the U.S. Food & Drug Administration (FDA) to rewrite the labels of these drugs to warn doctors and patients about the atypical femur fractures. The FDA is considering the task force’s results and will soon decide whether a label change will occur.

Fosamax Lawsuits / Actonel Lawsuits / Boniva Lawsuits

Fosamax lawsuits, Actonel lawsuits and Boniva lawsuits already filed against the manufacturers allege that the manufacturers knew about these increased risks and side effects, or should have known about them, and failed to warn consumers. If you’ve been injured by one of these potentially dangerous bisphosphonate drugs, contact an experienced Fosamax attorney as you may be entitled to damages such as medical bills, lost wages, pain and suffering and more.